Anticardiolipin Antibody Assay: a Methodological Analysis for a better Consensus in Routine Determinations
Authors:
- 1 January 2001
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 86 (08) , 575-583
Abstract
Summary: Despite the widely recognized practical importance of anticardiolipin (aCL) ELISA, the reliability of this test has been recently discussed. In order to investigate this area on European scale, we sent to 30 experienced centers a questionnaire focusing on the diagnostic procedures applied to patients with antiphospholipid syndrome (APS) and on the detailed protocols used to perform aCL. Anticardiolipin ELISA was found to be the most frequently performed test in patients with suspected APS, but significant difference was shown among the various protocols. The cross-laboratory multiple examination of ten serum samples evaluated independently by the 24 centers pointed out the difficulty in getting comparable results. Therefore a “consensus” protocol was derived from the aCL methods giving the best performance. The materials and reagents necessary to perform the “consensus” method, including, as putative standards, one IgG and one IgM monoclonal antibody (HCAL and EY2C9) were distributed to 19 Centers. The results of one IgG and one IgM aCL high positive sera measured in serial dilutions were compared. A progressive decrease in the variability of the values obtained for a given sample appeared evident when all the laboratories used the same standard, in their own in-house ELISA and even more in the “consensus” ELISA.Our data show that aCL ELISA standardization is necessary in order to obtain comparable results in different laboratories.Keywords
This publication has 11 references indexed in Scilit:
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approachPathology, 1999
- Many faces of lupus anticoagulantsLupus, 1998
- Multicenter Evaluation of Nine Commercial Kits for the Quantitation of Anticardiolipin AntibodiesThrombosis and Haemostasis, 1995
- Anticardiolipin Wet Workshop Report:Fifth International Symposium on Antiphospholipid AntibodiesAmerican Journal of Clinical Pathology, 1994
- Interlaboratory variation in antiphospholipid antibody testingAmerican Journal of Obstetrics and Gynecology, 1992
- Anticardiolipin antibody testing: the need for standardizationArthritis & Rheumatism, 1987
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- INTRAUTERINE DEATH AND CIRCULATING ANTICOAGULANT (“ANTITHROMBOPLASTIN”)Acta Medica Scandinavica, 1975
- Peripheral Vascular Syndromes Associated with Systemic Lupus ErythematosusAnnals of Internal Medicine, 1965